Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Voluntary Announcement Voluntary Lock-up Undertakings by Certain Shareholders

Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA

December 27, 2023 -- Boan Biotech today announced that two of its Claudin18.2-targeted investigational drugs have been granted the Orphan Drug Designation (ODD) for the treatment of pancreatic cancer ...

Both BA1105 and BA1301 Being Granted Orphan Drug Designations for Treatment of Pancreatic Cancer by the FDA

Finance Lease Agreement

List of directors and their roles and functions

Resignation of Non-Executive Director

List of Directors and their Roles and Functions

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023